Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Life Semantics Corp (347700:KRX), powered by AI.
Life Semantics Corp is currently trading at ₩40,050. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Life Semantics Corp on Alpha Lenz.
Life Semantics Corp's P/E ratio is 11952.9.
“Life Semantics Corp trades at a P/E of 11952.9 (premium valuation) with modest ROE of 0.4%. 3Y revenue CAGR of 223.7% highlights clear growth momentum.”
Ask for details →Life Semantics Corp is a pioneering company in the health technology sector. It specializes in developing advanced healthcare platforms and solutions that enhance patient care and health management. The company's primary function is to leverage digital technology and data analytics to improve the efficiency and effectiveness of medical services. Notable for its innovative health information systems, Life Semantics Corp impacts various sectors, including hospital management, telemedicine, and personalized medicine. By integrating cloud-based services and AI-driven insights, it enables healthcare providers to better manage patient records, streamline workflows, and deliver personalized healthcare experiences. In the context of the financial market, Life Semantics Corp plays a significant role as a driver of technological advancement in healthcare, offering transformative solutions that align with the growing demand for digital health innovations. By operating at the intersection of healthcare and technology, it represents a critical component of the evolving landscape of modern medical services.
“Life Semantics Corp trades at a P/E of 11952.9 (premium valuation) with modest ROE of 0.4%. 3Y revenue CAGR of 223.7% highlights clear growth momentum.”
Ask for details →Life Semantics Corp (ticker: 347700) is a company listed on KRX in the Healthcare sector (Health Information Services). Market cap is $2.0T.
The current price is ₩40,050 with a P/E ratio of 11,952.9x and P/B of 31.98x.
ROE is 0.36% and operating margin is 9.47%. Annual revenue is $95.6B.